logo

Ironwood Pharmaceuticals, Inc. (IRWD)



Trade IRWD now with
  Date
  Headline
8/13/2019 7:33:29 AM Ironwood Pharma, Alnylam Pharma Enter U.S. GI Disease Education And Promotional Agreement For Givosiran In AHP
8/8/2019 7:35:38 AM Ironwood Pharma Announces Pricing Of Upsized $350 Mln Convertible Senior Notes Offering
7/31/2019 9:22:06 AM Wedbush Is Lowering Ironwood Pharmaceuticals, Inc. (IRWD) FY19 Rev. Estimate To 381.4 M From 381.7 M
7/31/2019 9:21:53 AM Wedbush Is Lowering Ironwood Pharmaceuticals, Inc. (IRWD) Q4 19 Rev. Estimate To 104.6 M From 121.1 M
7/31/2019 9:21:41 AM Wedbush Is Raising Ironwood Pharmaceuticals, Inc. (IRWD) Q3 19 Rev. Estimate To 105.8 M From 99.8 M
7/31/2019 9:21:15 AM Wedbush Is Increasing Ironwood Pharmaceuticals, Inc. (IRWD) FY19 Estimate To -0.04 From -0.21
7/31/2019 9:18:13 AM Wedbush Is Cutting Ironwood Pharmaceuticals, Inc. (IRWD) Q4 19 Estimate To 0.13 From 0.17
7/31/2019 9:18:03 AM Wedbush Is Increasing Ironwood Pharmaceuticals, Inc. (IRWD) Q3 19 Estimate To 0.15 From 0.05
7/31/2019 9:17:08 AM Wedbush Reiterates Ironwood Pharmaceuticals, Inc. (IRWD) At Neutral With $12 Up From $11 Price Target
6/3/2019 8:50:01 AM Ironwood, Allergan Begin Patient Dosing In Phase II Clinical Trial Of MD-7246
5/6/2019 8:18:39 AM Wedbush Is Lowering Ironwood Pharmaceuticals, Inc. (IRWD) FY19 Rev. Estimate To 381.7 M From 388.5 M
5/6/2019 8:18:24 AM Wedbush Is Increasing Ironwood Pharmaceuticals, Inc. (IRWD) Q4 19 Rev. Estimate To 121.1 M From 100.3 M
5/6/2019 8:18:02 AM Wedbush Is Raising Ironwood Pharmaceuticals, Inc. (IRWD) Q3 19 Rev. Estimate To 99.8 M From 98.7 M
5/6/2019 8:17:40 AM Wedbush Is Lowering Ironwood Pharmaceuticals, Inc. (IRWD) Q2 19 Rev. Estimate To 92.0 M From 96.3 M
5/6/2019 8:17:13 AM Wedbush Is Lowering Ironwood Pharmaceuticals, Inc. (IRWD) FY19 Estimate To -0.21 From 0.08
5/6/2019 8:17:02 AM Wedbush Is Raising Ironwood Pharmaceuticals, Inc. (IRWD) Q4 19 Estimate To 0.17 From 0.16
5/6/2019 8:16:51 AM Wedbush Is Cutting Ironwood Pharmaceuticals, Inc. (IRWD) Q3 19 Estimate To 0.05 From 0.09
5/6/2019 8:16:05 AM Wedbush Reiterates Ironwood Pharmaceuticals, Inc. (IRWD) At Neutral With $11 Down From $14 Price Target
2/14/2019 9:18:37 AM Wedbush Is Cutting Ironwood Pharmaceuticals, Inc. (IRWD) FY19 Rev. Estimate To 388.5 M From 406.4 M
2/14/2019 9:18:23 AM Wedbush Is Cutting Ironwood Pharmaceuticals, Inc. (IRWD) Q4 19 Rev. Estimate To 100.3 M From 105.3 M